SLC5A12 and Autoimmunity: Additionally, our findings suggest that the inducible SLC5A12 lactate transporter represents an important checkpoint in autoimmunity, whereby both gene targeting and pharmacological blockade plastically modulate key inflammatory pathways that are specific to the local microenvironment in which ELS develop.